Rozeman Leida B, Hameetman Liesbeth, Cleton-Jansen Anne-Marie, Taminiau Anthonie H M, Hogendoorn Pancras C W, Bovée Judith V M G
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
J Pathol. 2005 Mar;205(4):476-82. doi: 10.1002/path.1723.
Enchondromas and conventional central chondrosarcomas are, respectively, benign and malignant hyaline cartilage-forming tumours that originate in the medulla of bone. In order to gain a better understanding of the molecular process underlying malignant transformation of enchondroma, and to investigate whether there is a biological difference between conventional central cartilaginous tumours and those of enchondromatosis or with phalangeal localization, a series of 64 enchondromas (phalanx, n = 21; enchondromatosis, n = 15) and 89 chondrosarcomas (phalanx, n = 17; enchondromatosis, n = 13) was collected. Indian Hedgehog (IHH)/parathyroid hormone related peptide (PTHrP) signalling, an important pathway in chondrocyte proliferation and differentiation within the normal growth plate, was studied by immunohistochemical analysis of the expression of PTHrP, PTHR1, Bcl-2, p21, cyclin D1, and cyclin E. Quantitative real-time PCR for IHH, PTCH, SMO, and GLI2 was performed on a subset of tumours. The data show that IHH signalling is absent in enchondromas and central chondrosarcomas, while PTHrP signalling is active. There was no difference in the expression of any of the molecules between 35 enchondromas and 26 grade I central chondrosarcomas, indicating that PTHrP signalling is not important in malignant transformation of enchondroma. Higher expression of PTHR1 and Bcl-2 was associated with increasing histological grade in chondrosarcoma, suggesting involvement in tumour progression. No difference was found between samples from enchondromatosis patients and solitary cases, suggesting no difference in PTHrP signalling. A small subset of phalangeal chondrosarcomas demonstrated down-regulation of PTHrP, which may be related to its more indolent clinical behaviour. Thus, in both enchondromas and central chondrosarcomas, PTHrP signalling is active and independent of IHH signalling, irrespective of the presence or absence of enchondromatosis.
内生软骨瘤和传统的中央型软骨肉瘤分别是起源于骨髓的良性和恶性透明软骨形成肿瘤。为了更好地理解内生软骨瘤恶性转化的分子过程,并研究传统的中央型软骨肿瘤与内生软骨瘤病或指骨定位的软骨肿瘤之间是否存在生物学差异,我们收集了一系列64例内生软骨瘤(指骨,n = 21;内生软骨瘤病,n = 15)和89例软骨肉瘤(指骨,n = 17;内生软骨瘤病,n = 13)。通过免疫组织化学分析甲状旁腺激素相关肽(PTHrP)、甲状旁腺激素受体1(PTHR1)、Bcl-2、p21、细胞周期蛋白D1和细胞周期蛋白E的表达,研究了印度刺猬因子(IHH)/甲状旁腺激素相关肽(PTHrP)信号通路,该信号通路是正常生长板中软骨细胞增殖和分化的重要途径。对一部分肿瘤进行了IHH、PTCH、SMO和GLI2的定量实时聚合酶链反应。数据显示,内生软骨瘤和中央型软骨肉瘤中不存在IHH信号,而PTHrP信号活跃。35例内生软骨瘤和26例I级中央型软骨肉瘤之间任何分子的表达均无差异,表明PTHrP信号在内生软骨瘤的恶性转化中并不重要。PTHR1和Bcl-2的高表达与软骨肉瘤组织学分级增加相关,提示其参与肿瘤进展。内生软骨瘤病患者的样本与单发病例之间未发现差异,提示PTHrP信号无差异。一小部分指骨软骨肉瘤表现出PTHrP下调,这可能与其更惰性的临床行为有关。因此,在内生软骨瘤和中央型软骨肉瘤中,无论是否存在内生软骨瘤病,PTHrP信号均活跃且独立于IHH信号。